BACKGROUND: Neurostructural alterations are often reported in first episode of psychosis (FEP), but there is heterogeneity in the direction and location of findings between individual studies. The reasons for this heterogeneity remain unknown. Obesity is disproportionately frequent already early in the course of psychosis and is associated with smaller brain volumes. Thus, we hypothesized that obesity may contribute to brain changes in FEP. METHOD: We analyzed MRI scans from 120 participants with FEP and 114 healthy participants. In primary analyses, we performed voxel-based morphometry (VBM) with small volume corrections to regions associated with FEP or obesity in previous meta-analyses. In secondary analyses, we performed whole-brain VBM analyses. RESULTS: In primary analyses, we found that when controlling for BMI, FEP had lower GM volume than healthy participants in a) left fronto-temporal region (pTFCE = 0.008) and b) left postcentral gyrus (pTFCE = 0.043). When controlling for FEP, BMI was associated with lower GM volume in left cerebellum (pTFCE < 0.001). In secondary analyses, we found that when controlling for BMI, FEP had lower GM volume than healthy participants in the a) cerebellum (pTFCE = 0.004), b) left frontal (pTFCE = 0.024), and c) right temporal cortex (pTFCE = 0.031). When controlling for FEP, BMI was associated with lower GM volume in cerebellum (pTFCE = 0.004). Levels of C-reactive protein, HDL and LDL-cholesterol correlated with obesity related neurostructural alterations. CONCLUSIONS: This study suggests that higher BMI, which is frequent in FEP, may contribute to cerebellar alterations in schizophrenia. As previous studies showed that obesity-related brain alterations may be reversible, our findings raise the possibility that improving the screening for and treatment of obesity and associated metabolic changes could preserve brain structure in FEP.

3rd Faculty of Medicine Charles University Prague Czechia

Department of Applied Neuroscience and Neuroimaging National Institute of Mental Health Klecany Czechia

Department of Complex Systems Institute of Computer Science of the Czech Academy of Sciences Prague Czechia

Department of Psychiatry Dalhousie University Halifax NS Canada

Zobrazit více v PubMed

Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, et al. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. Schizophr Bull (2015) 41:574–83.  10.1093/schbul/sbv024 PubMed DOI PMC

Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry (2001) 49:487–99. 10.1016/S0006-3223(01)01067-8 PubMed DOI

Leung M, Cheung C, Yu K, Yip B, Sham P, Li Q, et al. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull (2011) 37:199–211.  10.1093/schbul/sbp099 PubMed DOI PMC

Radua J, Borgwardt S, Crescini A, Mataix-Cols D, Meyer-Lindenberg A, McGuire PK, et al. Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neurosci Biobehav Rev (2012) 36:2325–33.  10.1016/j.neubiorev.2012.07.012 PubMed DOI

Shah C, Zhang W, Xiao Y, Yao L, Zhao Y, Gao X, et al. Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis. Psychol Med (2017) 47:401–13.  10.1017/S0033291716002683 PubMed DOI

Fornito A, Yücel M, Pantelis C. Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder. Curr Opin Psychiatry (2009) 22:312–9.  10.1097/YCO.0b013e32832a1353 PubMed DOI

Vita A, De Peri L, Silenzi C, Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr Res (2006) 82:75–88.  10.1016/j.schres.2005.11.004 PubMed DOI

Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M. Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull (2013) 39:295–305.  10.1093/schbul/sbs082 PubMed DOI PMC

Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry (2015) 14:339–47.  10.1002/wps.20252 PubMed DOI PMC

Correll CU, Robinson DG, Schooler NR, Brunette MF, Mueser KT, Rosenheck RA, et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry (2014) 71:1350–63.  10.1001/jamapsychiatry.2014.1314 PubMed DOI

Foley DL, Morley KI. Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. Arch Gen Psychiatry (2011) 68:609–16.  10.1001/archgenpsychiatry.2011.2 PubMed DOI

Galletly CA, Foley DL, Waterreus A, Watts GF, Castle DJ, McGrath JJ, et al. Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis. Aust N Z J Psychiatry (2012) 46:753–61.  10.1177/0004867412453089 PubMed DOI

Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders–a systematic review and meta-analysis. Schizophr Bull (2013) 39:306–18.  10.1093/schbul/sbr148 PubMed DOI PMC

Alosco ML, Stanek KM, Galioto R, Korgaonkar MS, Grieve SM, Brickman AM, et al. Body mass index and brain structure in healthy children and adolescents. Int J Neurosci (2014) 124:49–55.  10.3109/00207454.2013.817408 PubMed DOI

Yau PL, Kang EH, Javier DC, Convit A. Preliminary evidence of cognitive and brain abnormalities in uncomplicated adolescent obesity. Obes (Silver Spring) (2014) 22:1865–71.  10.1002/oby.20801 PubMed DOI PMC

Caunca MR, Gardener H, Simonetto M, Cheung YK, Alperin N, Yoshita M, et al. Measures of obesity are associated with MRI markers of brain aging: The Northern Manhattan Study. Neurology (2019) 93:e791–803.  10.1212/WNL.0000000000007966 PubMed DOI PMC

Dekkers IA, Jansen PR, Lamb HJ. Obesity, brain volume, and white matter microstructure at MRI: A Cross-sectional UK Biobank Study. Radiology (2019) 291:763–71.  10.1148/radiol.2019181012 PubMed DOI

García-García I, Michaud A, Dadar M, Zeighami Y, Neseliler S, Collins DL, et al. Neuroanatomical differences in obesity: meta-analytic findings and their validation in an independent dataset. Int J Obes 2005 (2019) 43:943–51.  10.1038/s41366-018-0164-4 PubMed DOI

Moberget T, Doan NT, Alnæs D, Kaufmann T, Córdova-Palomera A, Lagerberg TV, et al. Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls. Mol Psychiatry (2018) 23:1512–20.  10.1038/mp.2017.106 PubMed DOI

Raschpichler M, Straatman K, Schroeter ML, Arelin K, Schlögl H, Fritzsch D, et al. Abdominal fat distribution and its relationship to brain changes: the differential effects of age on cerebellar structure and function: a cross-sectional, exploratory study. BMJ Open (2013) 3.  10.1136/bmjopen-2012-001915 PubMed DOI PMC

Willette AA, Kapogiannis D. Does the brain shrink as the waist expands? Ageing Res Rev (2015) 20:86–97.  10.1016/j.arr.2014.03.007 PubMed DOI PMC

Kolenic M, Franke K, Hlinka J, Matejka M, Capkova J, Pausova Z, et al. Obesity, dyslipidemia and brain age in first-episode psychosis. J Psychiatr Res (2018) 99:151–8.  10.1016/j.jpsychires.2018.02.012 PubMed DOI

Spaniel F, Tintera J, Rydlo J, Ibrahim I, Kasparek T, Horacek J, et al. Altered neural correlate of the self-agency experience in first-episode Schizophrenia-spectrum patients: An fMRI Study. Schizophr Bull (2016) 42:916–25.  10.1093/schbul/sbv188 PubMed DOI PMC

Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 59 Suppl 20:22–33;quiz 34-57. PubMed

Fusar-Poli P, Cappucciati M, Rutigliano G, Heslin M, Stahl D, Brittenden Z, et al. Diagnostic stability of ICD/DSM first episode psychosis diagnoses: meta-analysis. Schizophr Bull (2016) 42:1395–406.  10.1093/schbul/sbw020 PubMed DOI PMC

Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull (1987) 13:261–76.  10.1093/schbul/13.2.261 PubMed DOI

Douaud G, Smith S, Jenkinson M, Behrens T, Johansen-Berg H, Vickers J, et al. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain J Neurol (2007) 130:2375–86.  10.1093/brain/awm184 PubMed DOI

Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ. Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage (2001) 14:21–36.  10.1006/nimg.2001.0786 PubMed DOI

Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage (2004) 23 Suppl 1:S208–219.  10.1016/j.neuroimage.2004.07.051 PubMed DOI

Andersson JLR, Jenkinson M, Smith S, Jenkinson M, Smith S, Andersson JLR, et al. Non-Linear Registration aka Spatial Normalisation FMRIB Technial Report TR07JA2 (2007). Available at: https://www.scienceopen.com/document?vid=13f3b9a9-6e99-4ae7-bea2-c1bf0af8ca6e (Accessed August 2, 2019).

Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage (2009) 44:83–98.  10.1016/j.neuroimage.2008.03.061 PubMed DOI

De Backer G. European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur Heart J (2003) 24:1601–10.  10.1016/S0195-668X(03)00347-6 PubMed DOI

Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev (2013) 37:1680–91.  10.1016/j.neubiorev.2013.06.001 PubMed DOI PMC

van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, et al. Cortical brain abnormalities in 4474 individuals with Schizophrenia and 5098 control subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biol Psychiatry (2018) 84:644–54.  10.1016/j.biopsych.2018.04.023 PubMed DOI PMC

Dean DJ, Bernard JA, Orr JM, Pelletier-Baldelli A, Gupta T, Carol EE, et al. Cerebellar morphology and procedural learning impairment in neuroleptic-naive youth at ultrahigh risk of psychosis. Clin Psychol Sci J Assoc Psychol Sci (2014) 2:152–64.  10.1177/2167702613500039 PubMed DOI PMC

He H, Luo C, Luo Y, Duan M, Yi Q, Biswal BB, et al. Reduction in gray matter of cerebellum in schizophrenia and its influence on static and dynamic connectivity. Hum Brain Mapp (2019) 40:517–28.  10.1002/hbm.24391 PubMed DOI PMC

Laidi C, Hajek T, Spaniel F, Kolenic M, d’Albis M-A, Sarrazin S, et al. Cerebellar parcellation in schizophrenia and bipolar disorder. Acta Psychiatr Scand (2019) 140(5):468–76.  10.1111/acps.13087 PubMed DOI

Laidi C, d’Albis M-A, Wessa M, Linke J, Phillips ML, Delavest M, et al. Cerebellar volume in schizophrenia and bipolar I disorder with and without psychotic features. Acta Psychiatr Scand (2015) 131:223–33.  10.1111/acps.12363 PubMed DOI PMC

Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 361:281–8.  10.1016/S0140-6736(03)12323-9 PubMed DOI

Venkatasubramanian G. Neuroanatomical correlates of psychopathology in antipsychotic-naive schizophrenia. Indian J Psychiatry (2010) 52:28.  10.4103/0019-5545.58892 PubMed DOI PMC

Wang J, Zhou L, Cui C, Liu Z, Lu J. Gray matter morphological anomalies in the cerebellar vermis in first-episode schizophrenia patients with cognitive deficits. BMC Psychiatry (2017) 17:374.  10.1186/s12888-017-1543-4 PubMed DOI PMC

Job DE, Whalley HC, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. NeuroImage (2005) 25:1023–30.  10.1016/j.neuroimage.2005.01.006 PubMed DOI

Vachharajani V, Granger DN. Adipose tissue: a motor for the inflammation associated with obesity. IUBMB Life (2009) 61:424–30.  10.1002/iub.169 PubMed DOI PMC

Jefferson AL, Massaro JM, Wolf PA, Seshadri S, Au R, Vasan RS, et al. Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study. Neurology (2007) 68:1032–8.  10.1212/01.wnl.0000257815.20548.df PubMed DOI PMC

Wisse BE. The Inflammatory Syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol (2004) 15:2792–800.  10.1097/01.ASN.0000141966.69934.21 PubMed DOI

Ursache A, Wedin W, Tirsi A, Convit A. Preliminary evidence for obesity and elevations in fasting insulin mediating associations between cortisol awakening response and hippocampal volumes and frontal atrophy. Psychoneuroendocrinology (2012) 37:1270–6.  10.1016/j.psyneuen.2011.12.020 PubMed DOI PMC

Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci (2006) 8:13. PubMed PMC

Rajagopalan P, Toga AW, Jack CR, Weiner MW, Thompson PM. Fat-mass-related hormone, plasma leptin, predicts brain volumes in the elderly. NeuroReport (2013) 24:58–62.  10.1097/WNR.0b013e32835c5254 PubMed DOI PMC

Hajek T, Calkin C, Blagdon R, Slaney C, Uher R, Alda M. Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders. Neuropsychopharmacology (2014) 39:2910–8.  10.1038/npp.2014.148 PubMed DOI PMC

Willette AA, Xu G, Johnson SC, Birdsill AC, Jonaitis EM, Sager MA, et al. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care (2013) 36:443–9.  10.2337/dc12-0922 PubMed DOI PMC

Phillips OR, Onopa AK, Zaiko YV, Singh MK. Insulin resistance is associated with smaller brain volumes in a preliminary study of depressed and obese children. Pediatr Diabetes (2018) 19:892–7.  10.1111/pedi.12672 PubMed DOI PMC

Castro K, Ntranos A, Amatruda M, Petracca M, Kosa P, Chen EY, et al. Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course. EBioMedicine (2019) 43:392–410.  10.1016/j.ebiom.2019.03.087 PubMed DOI PMC

Guillemot-Legris O, Masquelier J, Everard A, Cani PD, Alhouayek M, Muccioli GG. High-fat diet feeding differentially affects the development of inflammation in the central nervous system. J Neuroinflammation (2016) 13:206.  10.1186/s12974-016-0666-8 PubMed DOI PMC

Guillemot-Legris O, Muccioli GG. Obesity-induced neuroinflammation: beyond the hypothalamus. Trends Neurosci (2017) 40:237–53.  10.1016/j.tins.2017.02.005 PubMed DOI

Tapia-González S, García-Segura LM, Tena-Sempere M, Frago LM, Castellano JM, Fuente-Martín E, et al. Activation of microglia in specific hypothalamic nuclei and the cerebellum of adult rats exposed to neonatal overnutrition. J Neuroendocrinol (2011) 23:365–70.  10.1111/j.1365-2826.2011.02113.x PubMed DOI

Vita A, De Peri L, Deste G, Sacchetti E. Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry (2012) 2:e190.  10.1038/tp.2012.116 PubMed DOI PMC

Bak M, Fransen A, Janssen J, van Os J, Drukker M. Almost all antipsychotics result in weight gain: a meta- analysis. PloS One (2014) 9:19. 10.1371/journal.pone.0094112 PubMed DOI PMC

Spertus J, Horvitz-Lennon M, Abing H, Normand S-L. Risk of weight gain for specific antipsychotic drugs: a meta-analysis. NPJ Schizophr (2018) 4:12.  10.1038/s41537-018-0053-9 PubMed DOI PMC

Vita A, De Peri L, Deste G, Barlati S, Sacchetti E. The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies. Biol Psychiatry (2015) 78:403–12.  10.1016/j.biopsych.2015.02.008 PubMed DOI

Andreasen NC, Liu D, Ziebell S, Vora A, Ho B-C. Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry (2013) 170:609–15.  10.1176/appi.ajp.2013.12050674 PubMed DOI PMC

Van Gestel H, Franke K, Petite J, Slaney C, Garnham J, Helmick C, et al. Brain age in bipolar disorders: Effects of lithium treatment. Aust N Z J Psychiatry (2019) 53(12):1179–88.  10.1177/0004867419857814 PubMed DOI

Minichino A, Ando’ A, Francesconi M, Salatino A, Delle Chiaie R, Cadenhead K. Investigating the link between drug-naive first episode psychoses (FEPs), weight gain abnormalities and brain structural damages: Relevance and implications for therapy. Prog Neuropsychopharmacol Biol Psychiatry (2017) 77:9–22.  10.1016/j.pnpbp.2017.03.020 PubMed DOI

Fava GA. The clinical role of psychological well-being. World Psychiatry (2012) 11:102–3. 10.1016/j.wpsyc.2012.05.018 PubMed DOI PMC

Goracci A, Rucci P, Forgione RN, Campinoti G, Valdagno M, Casolaro I, et al. Development, acceptability and efficacy of a standardized healthy lifestyle intervention in recurrent depression. J Affect Disord (2016) 196:20–31.  10.1016/j.jad.2016.02.034 PubMed DOI

Gomez-Pinilla F. The combined effects of exercise and foods in preventing neurological and cognitive disorders. Prev Med (2011) 52 Suppl 1:S75–80.  10.1016/j.ypmed.2011.01.023 PubMed DOI PMC

Haltia LT, Viljanen A, Parkkola R, Kemppainen N, Rinne JO, Nuutila P, et al. Brain white matter expansion in human obesity and the recovering effect of dieting. J Clin Endocrinol Metab (2007) 92:3278–84.  10.1210/jc.2006-2495 PubMed DOI

Mueller K, Möller HE, Horstmann A, Busse F, Lepsien J, Blüher M, et al. Physical exercise in overweight to obese individuals induces metabolic- and neurotrophic-related structural brain plasticity. Front Hum Neurosci (2015) 9:372.  10.3389/fnhum.2015.00372 PubMed DOI PMC

Shan H, Li P, Liu H, Nie B, Yin X, Zhang T, et al. Gray matter reduction related to decreased serum creatinine and increased triglyceride, Hemoglobin A1C, and low-density lipoprotein in subjects with obesity. Neuroradiology (2019) 61:703–10.  10.1007/s00234-019-02202-3 PubMed DOI

Tuulari JJ, Karlsson HK, Antikainen O, Hirvonen J, Pham T, Salminen P, et al. Bariatric surgery induces white and grey matter density recovery in the morbidly obese: A Voxel-Based Morphometric Study. Hum Brain Mapp (2016) 37:3745–56. 10.1002/hbm.23272 PubMed DOI PMC

Pajonk F-G, Wobrock T, Gruber O, Scherk H, Berner D, Kaizl I, et al. Hippocampal plasticity in response to exercise in schizophrenia. Arch Gen Psychiatry (2010) 67:133–43.  10.1001/archgenpsychiatry.2009.193 PubMed DOI

Honea RA, Szabo-Reed AN, Lepping RJ, Perea R, Breslin F, Martin LE, et al. Voxel-based morphometry reveals brain gray matter volume changes in successful dieters. Obes Silver Spring Md (2016) 24:1842–8.  10.1002/oby.21551 PubMed DOI PMC

Gejl M, Gjedde A, Egefjord L, Møller A, Hansen SB, Vang K, et al. In Alzheimer’s disease, 6-month treatment with glp-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial. Front Aging Neurosci (2016) 8:108.  10.3389/fnagi.2016.00108 PubMed DOI PMC

Mansur RB, Ahmed J, Cha DS, Woldeyohannes HO, Subramaniapillai M, Lovshin J, et al. Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study. J Affect Disord (2017) 207:114–20.  10.1016/j.jad.2016.09.056 PubMed DOI

Mansur RB, Zugman A, Ahmed J, Cha DS, Subramaniapillai M, Lee Y, et al. Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol (2017) 27:1153–62.  10.1016/j.euroneuro.2017.08.433 PubMed DOI

Watson S, Gallagher P, Porter RJ, Smith MS, Herron LJ, Bulmer S, et al. A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biol Psychiatry (2012) 72:943–9.  10.1016/j.biopsych.2012.05.029 PubMed DOI

Gross C, Blasey CM, Roe RL, Allen K, Block TS, Belanoff JK. Mifepristone treatment of olanzapine-induced weight gain in healthy men. Adv Ther (2009) 26:959–69.  10.1007/s12325-009-0070-1 PubMed DOI

Gross C, Blasey CM, Roe RL, Belanoff JK. Mifepristone Reduces Weight Gain and Improves Metabolic Abnormalities Associated With Risperidone Treatment in Normal Men. Obesity (2010) 18:2295–300.  10.1038/oby.2010.51 PubMed DOI

Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschöp MH. Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci USA (2008) 105:9793–8.  10.1073/pnas.0802917105 PubMed DOI PMC

Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res (2007) 100:1512–21.  10.1161/01.RES.0000267723.65696.4a PubMed DOI

Wyman AE, Atamas SP. Sirtuins and accelerated aging in scleroderma. Curr Rheumatol Rep (2018) 20:16.  10.1007/s11926-018-0724-6 PubMed DOI PMC

Andreasen NC, Pierson R. The role of the cerebellum in schizophrenia. Biol Psychiatry (2008) 64:81–8.  10.1016/j.biopsych.2008.01.003 PubMed DOI PMC

Buckner RL. The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron (2013) 80:807–15.  10.1016/j.neuron.2013.10.044 PubMed DOI

Stoodley CJ, Schmahmann JD. Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. NeuroImage (2009) 44:489–501.  10.1016/j.neuroimage.2008.08.039 PubMed DOI

Calkin C, van de Velde C, Růžičková M, Slaney C, Garnham J, Hajek T, et al. Can body mass index help predict outcome in patients with bipolar disorder? Bipolar Disord (2009) 11:650–6.  10.1111/j.1399-5618.2009.00730.x PubMed DOI PMC

Godin O, Leboyer M, Schürhoff F, Llorca P-M, Boyer L, Andre M, et al. Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort. J Clin Psychiatry (2018) 79.  10.4088/JCP.17m12007 PubMed DOI

Manu P, Khan S, Radhakrishnan R, Russ MJ, Kane JM, Correll CU. Body mass index identified as an independent predictor of psychiatric readmission. J Clin Psychiatry (2014) 75:e573–577.  10.4088/JCP.13m08795 PubMed DOI

Phillips JR, Hewedi DH, Eissa AM, Moustafa AA. The cerebellum and psychiatric disorders. Front Public Health (2015) 3:66.  10.3389/fpubh.2015.00066 PubMed DOI PMC

Cox SR, Lyall DM, Ritchie SJ, Bastin ME, Harris MA, Buchanan CR, et al. Associations between vascular risk factors and brain MRI indices in UK Biobank. Eur Heart J (2019) 40:2290–300.  10.1093/eurheartj/ehz100 PubMed DOI PMC

Hamer M, Batty GD. Association of body mass index and waist-to-hip ratio with brain structure: UK Biobank study. Neurology (2019) 92:e594–600.  10.1212/WNL.0000000000006879 PubMed DOI PMC

Miquel M, Vazquez-Sanroman D, Carbo-Gas M, Gil-Miravet I, Sanchis-Segura C, Carulli D, et al. Have we been ignoring the elephant in the room? Seven arguments for considering the cerebellum as part of addiction circuitry. Neurosci Biobehav Rev (2016) 60:1–11.  10.1016/j.neubiorev.2015.11.005 PubMed DOI

Opel N, Redlich R, Grotegerd D, Dohm K, Heindel W, Kugel H, et al. Obesity and major depression: Body-mass index (BMI) is associated with a severe course of disease and specific neurostructural alterations. Psychoneuroendocrinology (2015) 51:219–26.  10.1016/j.psyneuen.2014.10.001 PubMed DOI

Schilling C, Kühn S, Paus T, Romanowski A, Banaschewski T, Barbot A, et al. Cortical thickness of superior frontal cortex predicts impulsiveness and perceptual reasoning in adolescence. Mol Psychiatry (2013) 18:624–30.  10.1038/mp.2012.56 PubMed DOI

Islam AH, Metcalfe AWS, MacIntosh BJ, Korczak DJ, Goldstein BI. Greater body mass index is associated with reduced frontal cortical volumes among adolescents with bipolar disorder. J Psychiatry Neurosci (2018) 43:120–30.  10.1503/jpn.170041 PubMed DOI PMC

Obesity and brain structure in schizophrenia - ENIGMA study in 3021 individuals

Diagnosis of bipolar disorders and body mass index predict clustering based on similarities in cortical thickness-ENIGMA study in 2436 individuals

Association between body mass index and subcortical brain volumes in bipolar disorders-ENIGMA study in 2735 individuals

Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis-A Longitudinal Study